skip to main content
Show Results with:

Results 1 - 10 of 13  for Everything in this catalogue

results 1 2 next page
Refined by: publisher: Elsevier remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, Omar et al.

European journal of cancer. Volume 107 (2019); pp 8-14 -- Elsevier

Online access

2
Material Type:
Article
Add to My workspace

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, Omar et al.

European journal of cancer. Volume 107: (2019, January); pp 8-14 -- Elsevier

Online access

3
Material Type:
Article
Add to My workspace

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort

Gautschi, Oliver et al.

Journal of thoracic oncology -- Elsevier -- Volume: 10 10; (pages 1451-1457) -- 2015

Online access

4
Material Type:
Article
Add to My workspace

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer

Gautschi, Oliver et al.

Journal of thoracic oncology. Volume 10:Issue 10 (2015, October) -- Elsevier

Online access

5
Material Type:
Article
Add to My workspace

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort

Gautschi, Oliver et al.

Journal of thoracic oncology. Volume 10:Issue 10 (2015, October) -- Elsevier

Online access

6
Material Type:
Article
Add to My workspace

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

Pless, Miklos et al.

The lancet. Volume 386:Issue 9998 (2015); pp 1049-1056 -- Elsevier

Online access

7
Material Type:
Article
Add to My workspace

Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non–Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial

Gautschi, Oliver et al.

Clinical lung cancer. Volume 18:Issue 3 (2017); pp 303-309 -- Elsevier

Online access

8
Material Type:
Article
Add to My workspace

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

Rosell, Rafael et al.

The lancet. Respiratory medicine. Volume 5:Number 5 (2017, May); pp 435-444 -- Elsevier

Online access

9
Material Type:
Article
Add to My workspace

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

Rosell, Rafael et al.

The lancet. Respiratory medicine. Volume 5:Issue 5 (2017); pp 435-444 -- Elsevier

Online access

10
Material Type:
Article
Add to My workspace

2861 Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)

Siano, M. et al.

European journal of cancer. Volume 51: (2015) Supplement 3; pp S576-S577 -- Elsevier

Online access

Results 1 - 10 of 13  for Everything in this catalogue

results 1 2 next page

Refine Search Results

Creation date 

From To

Additional Features 

  1. Abstract  (9)
  2. No Abstract  (4)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait